Union Health Minister J P Nadda today spoke to All India Organisation of Chemists and Druggists (AIOCD) president J S Shinde and clarified that no such decision has been taken by the government.
"The Union Minister clarified that no such decision has been taken by the government. He informed them that views of all stakeholders will be taken into account as and when the matter is taken up for consideration by the government," an official statement said.
"The government's move towards regularising the sale of medicines through internet would increase the risk of adverse drug reaction, which will give an opening for the entry of low-quality...Mis-branded and spurious products. Entering of low-quality products will have a major setback economically, which is estimated to hit eight lakh chemists and about 80 lakh workers and their families," Shinde had said yesterday.
The Union Health Ministry statement said that to clarify the matter, a meeting was held between senior officials of the Ministry and AIOCD on October 12 where the office bearers of the organisation were informed that a number of representations have been received both for and against this proposal.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
